Sterling Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$596K Sell
2,367
-173
-7% -$37.2K 0.33% 49
2026
Q1
$552K Sell
2,540
-7,304
-74% -$1.62M 0.33% 49
2025
Q4
$2.25M Sell
9,844
-65
-0.7% -$14.8K 1.28% 24
2025
Q3
$2.29M Sell
9,909
-4,330
-30% -$882K 1.38% 25
2025
Q2
$2.64M Sell
14,239
-67
-0.5% -$12.5K 1.75% 21
2025
Q1
$3M Sell
14,306
-472
-3% -$91.8K 2.13% 17
2024
Q4
$2.63M Sell
14,778
-212
-1% -$39K 2.06% 16
2024
Q3
$2.96M Sell
14,990
-1,011
-6% -$189K 2.25% 13
2024
Q2
$2.74M Sell
16,001
-4,173
-21% -$691K 2.09% 13
2024
Q1
$3.67M Sell
20,174
-289
-1% -$49.8K 2.59% 10
2023
Q4
$3.17M Sell
20,463
-445
-2% -$64.9K 2.33% 13
2023
Q3
$3.12M Sell
20,908
-355
-2% -$52.1K 2.77% 7
2023
Q2
$2.86M Sell
21,263
-280
-1% -$41.1K 2.27% 11
2023
Q1
$3.43M Sell
21,543
-336
-2% -$51.4K 2.73% 7
2022
Q4
$3.54M Sell
21,879
-1,533
-7% -$235K 2.84% 6
2022
Q3
$3.14M Buy
23,412
+3,242
+16% +$465K 2.65% 7
2022
Q2
$3.09M Sell
20,170
-670
-3% -$102K 2.57% 7
2022
Q1
$3.38M Sell
20,840
-5,006
-19% -$727K 2.38% 10
2021
Q4
$3.5M Sell
25,846
-472
-2% -$55.8K 2.18% 12
2021
Q3
$2.84M Buy
26,318
+5,231
+25% +$598K 1.81% 15
2021
Q2
$2.38M Sell
21,087
-7,301
-26% -$822K 1.56% 20
2021
Q1
$3.07M Sell
28,388
-951
-3% -$102K 2.1% 14
2020
Q4
$3.14M Sell
29,339
-2,801
-9% -$269K 2.23% 14
2020
Q3
$2.81M Buy
32,140
+12,747
+66% +$1.2M 2.1% 13
2020
Q2
$1.9M Buy
19,393
+11,009
+131% +$969K 1.47% 21
2020
Q1
$639K Buy
+8,384
New +$714K 0.56% 43

Other funds holding ABBV

Sterling Investment Management's ABBV Position: Q2 2026 in Review

Sterling Investment Management reduced its AbbVie (ABBV) stake by 6.8% in Q2 2026, selling an estimated $37.2K and leaving 2,367 shares worth $596K. The position accounts for 0.33% of the portfolio, ranked #49.

Sterling Investment Management first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.67M in Q1 2024. 1,264 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sterling Investment Management held 2,367 shares of AbbVie worth $596K as of Q2 2026.
  • Sterling Investment Management sold 173 AbbVie shares in Q2 2026, an estimated $37.2K.
  • AbbVie made up 0.33% of Sterling Investment Management's portfolio in Q2 2026, its #49 holding.
  • Sterling Investment Management first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • Sterling Investment Management's AbbVie position peaked at $3.67M in Q1 2024.
  • 1,264 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sterling Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.